Sažetak By supressing the renin–angiotensin–aldosterone system (RAAS), angiotensin-
converting-enzyme inhibitors (ACE inhibitors) are particularly important in treating essential …

The present study was undertaken to investigate the effects of losartan, a non-peptide
angiotensin II subtype 1 (AT1) receptor antagonist, on both the pressor responses elicited by …

Mit der Zulassung der ACE-Hemmer 1981 in der Bundesrepublik Deutschland stand eine
antihypertensive Substanzklasse zur Verfügung, die einen Eingriff in das ReninAngiotensin …

Sažetak Suprimirajući renin-angiotenzin-aldosteronski sustav (RAAS), inhibitori enzima koji
konvertira angiotenzin (prema engl. angiotensin-converting-enzyme–ACE) imaju posebno …

Sandoz Irbesartan est indiqué dans le traitement de:• l'hypertension essentielle. Sandoz
Irbesartan peut être administré en monothérapie ou en association avec un diurétique …

Objective A prospective open multicentre study was conducted in patients with mild-to-
moderate hypertension to compare the efficacy on diastolic blood pressure (DBP) and …

L'irbesartan inhibe les effets de vasoconstriction et de sécrétion d'aldostérone de
l'angiotensine II, en bloquant spécifiquement, de façon non compétitive, sa liaison aux …

The RAS has long been regarded as an exclusively endocrine system. The cascade
resulting in bioactive products starts with angiotensinogen, an α-globulin which derives from …

Background: Hypertension is a multifactorial disease, with angiotensin II (Ang II) as the
established target of pharmacological intervention. However, there has been increasing …

In Japan, ambulatory blood pressure monitoring (ABPM) became covered by health
insurance in April 2008. In The Japanese Society of Hypertension Guidelines for the …